FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285494313> ?p ?o ?g. }

• W4285494313 abstract "The recent interaction cross-section-based formulation for radiation-induced direct cellular inactivation, mild and severe sublethal damage, DNA-repair and cell survival have been developed to accurately describe cellular repair, misrepair and apoptosis in TP53 wild-type and mutant cells. The principal idea of this new non-homologous repairable-homologous repairable (RHR) damage formulation is to separately describe the mild damage that can be rapidly handled by the most basic repair processes including the non-homologous end joining (NHEJ), and more complex damage requiring longer repair times and high-fidelity homologous recombination (HR) repair. Taking the interaction between these two key mammalian DNA repair processes more accurately into account has significantly improved the method as indicated in the original publication. Based on the principal mechanisms of 7 repair and 8 misrepair processes presently derived, it has been possible to quite accurately describe the probability that some of these repair processes when unsuccessful can induce cellular apoptosis with increasing doses of γrays, boron ions and PRIMA-1. Interestingly, for all LETs studied (≈0.3–160 eV/nm) the increase in apoptosis saturates when the cell survival reaches about 10% and the fraction of un-hit cells is well below the 1% level. It is shown that most of the early cell kill for low-to-medium LETs are due to apoptosis since the cell survival as well as the non-apoptotic cells agree very well at low doses and other death processes dominate beyond D > 1 Gy. The low-dose apoptosis is due to the fact that the full activation of the checkpoint kinases ATM and Chk2 requires >8 and >18 DSBs per cell to phosphorylate p53 at serine 15 and 20. Therefore, DNA repair is not fully activated until well after 1/2 Gy, and the cellular response may be apoptotic by default before the low-dose hyper sensitivity (LDHS) is replaced by an increased radiation tolerance as the DNA repair processes get maximal efficiency. In effect, simultaneously explaining the LDHS and inverse dose rate phenomena. The partial contributions by the eight newly derived misrepair processes was determined so they together accurately described the experimental apoptosis induction data for γ rays and boron ions. Through these partial misrepair contributions it was possible to predict the apoptotic response based solely on carefully analyzed cell survival data, demonstrating the usefulness of an accurate DNA repair-based cell survival approach. The peak relative biological effectiveness (RBE) of the boron ions was 3.5 at 160 eV/nm whereas the analogous peak relative apoptotic effectiveness (RAE) was 3.4 but at 40 eV/nm indicating the clinical value of the lower LET light ions (15 ≤ LET ≤ 55 eV/nm, 2 ≤ Z ≤5) in therapeutic applications to maximize tumor apoptosis and senescence. The new survival expressions were also applied on mouse embryonic fibroblasts with key knocked-out repair genes, showing a good agreement between the principal non-homologous and homologous repair terms and also a reasonable prediction of the associated apoptotic induction. Finally, the formulation was used to estimate the increase in DNA repair and apoptotic response in combination with the mutant p53 reactivating compound PRIMA-1 and γ rays, indicating a 10–2 times increase in apoptosis with 5 µM of the compound reaching apoptosis levels not far from peak apoptosis boron ions in a TP53 mutant cell line. To utilize PRIMA-1 induced apoptosis and cellular sensitization for reactive oxygen species (ROS), concomitant biologically optimized radiation therapy is proposed to maximize the complication free tumor cure for the multitude of TP53 mutant tumors seen in the clinic. The experimental data also indicated the clinically very important high-absorbed dose ROS effect of PRIMA-1." @default.
• W4285494313 created "2022-07-15" @default.
• W4285494313 creator A5003138660 @default.
• W4285494313 date "2022-07-14" @default.
• W4285494313 modified "2023-09-30" @default.
• W4285494313 title "Quantifying Cellular Repair, Misrepair and Apoptosis Induced by Boron Ions, Gamma Rays and PRIMA-1 Using the RHR Formulation" @default.
• W4285494313 cites W1917341586 @default.
• W4285494313 cites W1963842583 @default.
• W4285494313 cites W1964957202 @default.
• W4285494313 cites W1978782811 @default.
• W4285494313 cites W1979568780 @default.
• W4285494313 cites W1987721350 @default.
• W4285494313 cites W1996813579 @default.
• W4285494313 cites W2011997876 @default.
• W4285494313 cites W2019276374 @default.
• W4285494313 cites W2020203596 @default.
• W4285494313 cites W2033102711 @default.
• W4285494313 cites W2042740031 @default.
• W4285494313 cites W2056802151 @default.
• W4285494313 cites W2070701799 @default.
• W4285494313 cites W2087187996 @default.
• W4285494313 cites W2090251492 @default.
• W4285494313 cites W2099990619 @default.
• W4285494313 cites W2109777886 @default.
• W4285494313 cites W2112651905 @default.
• W4285494313 cites W2117482427 @default.
• W4285494313 cites W2120943086 @default.
• W4285494313 cites W2140210955 @default.
• W4285494313 cites W2150152824 @default.
• W4285494313 cites W2150964381 @default.
• W4285494313 cites W2152002544 @default.
• W4285494313 cites W2153404980 @default.
• W4285494313 cites W2158168200 @default.
• W4285494313 cites W2212776653 @default.
• W4285494313 cites W2236236168 @default.
• W4285494313 cites W2265132046 @default.
• W4285494313 cites W2276371085 @default.
• W4285494313 cites W2296534952 @default.
• W4285494313 cites W2341866865 @default.
• W4285494313 cites W2474601761 @default.
• W4285494313 cites W2559795396 @default.
• W4285494313 cites W2772062014 @default.
• W4285494313 cites W2804810112 @default.
• W4285494313 cites W2887430569 @default.
• W4285494313 cites W2893184302 @default.
• W4285494313 cites W2896636136 @default.
• W4285494313 cites W2899927945 @default.
• W4285494313 cites W2909996148 @default.
• W4285494313 cites W2932666635 @default.
• W4285494313 cites W2951449583 @default.
• W4285494313 cites W2954763280 @default.
• W4285494313 cites W2971625273 @default.
• W4285494313 cites W2993621128 @default.
• W4285494313 cites W3004203069 @default.
• W4285494313 cites W3004546141 @default.
• W4285494313 cites W3049399239 @default.
• W4285494313 cites W3082544065 @default.
• W4285494313 cites W3085622264 @default.
• W4285494313 cites W3094395021 @default.
• W4285494313 cites W3097153985 @default.
• W4285494313 cites W3102190419 @default.
• W4285494313 cites W3103421174 @default.
• W4285494313 cites W3187829407 @default.
• W4285494313 cites W3191911259 @default.
• W4285494313 cites W4233691503 @default.
• W4285494313 cites W4248347759 @default.
• W4285494313 cites W4280568153 @default.
• W4285494313 cites W746743940 @default.
• W4285494313 doi "https://doi.org/10.1667/rade-22-00011.1" @default.
• W4285494313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35834822" @default.
• W4285494313 hasPublicationYear "2022" @default.
• W4285494313 type Work @default.
• W4285494313 citedByCount "2" @default.
• W4285494313 countsByYear W42854943132023 @default.
• W4285494313 crossrefType "journal-article" @default.
• W4285494313 hasAuthorship W4285494313A5003138660 @default.
• W4285494313 hasConcept C102744134 @default.
• W4285494313 hasConcept C104317684 @default.
• W4285494313 hasConcept C122917832 @default.
• W4285494313 hasConcept C12554922 @default.
• W4285494313 hasConcept C134935766 @default.
• W4285494313 hasConcept C143065580 @default.
• W4285494313 hasConcept C143425029 @default.
• W4285494313 hasConcept C1491633281 @default.
• W4285494313 hasConcept C185592680 @default.
• W4285494313 hasConcept C190283241 @default.
• W4285494313 hasConcept C31573885 @default.
• W4285494313 hasConcept C54355233 @default.
• W4285494313 hasConcept C552990157 @default.
• W4285494313 hasConcept C86803240 @default.
• W4285494313 hasConcept C95444343 @default.
• W4285494313 hasConceptScore W4285494313C102744134 @default.
• W4285494313 hasConceptScore W4285494313C104317684 @default.
• W4285494313 hasConceptScore W4285494313C122917832 @default.
• W4285494313 hasConceptScore W4285494313C12554922 @default.
• W4285494313 hasConceptScore W4285494313C134935766 @default.
• W4285494313 hasConceptScore W4285494313C143065580 @default.
• W4285494313 hasConceptScore W4285494313C143425029 @default.
• W4285494313 hasConceptScore W4285494313C1491633281 @default.
• W4285494313 hasConceptScore W4285494313C185592680 @default.

• next